Study of PRX-03140 Monotherapy in Subjects With Alzheimer's Disease
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
A randomized placebo-controlled study to evaluate the efficacy of PRX-03140 monotherapy in
subjects with Alzheimer's disease. The study consists of a 3-month double-blind treatment
period and an optional 3-month extension period.